Cargando…
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study
BACKGROUND: Vulnerable dialysis and kidney transplant patients show impaired seroconversion rates compared to medical personnel eight weeks after SARS-CoV-2mRNA vaccination. METHODS: We evaluated six months follow up data in our observational Dia-Vacc study exploring specific cellular (interferon-γ...
Autores principales: | Stumpf, Julian, Schwöbel, Jörg, Lindner, Tom, Anders, Leona, Siepmann, Torsten, Karger, Claudia, Hüther, Jan, Martin, Heike, Müller, Petra, Faulhaber-Walter, Robert, Langer, Torsten, Schirutschke, Holger, Stehr, Thomas, Meistring, Frank, Pietzonka, Annegret, Anding-Rost, Kirsten, Escher, Katja, Pistrosch, Frank, Schewe, Jens, Seidel, Harald, Barnett, Kerstin, Pluntke, Thilo, Cerny, Simon, Paliege, Alexander, Bast, Ingolf, Steglich, Anne, Gembardt, Florian, Kessel, Friederike, Kröger, Hannah, Arndt, Patrick, Sradnick, Jan, Frank, Kerstin, Klimova, Anna, Mauer, René, Grählert, Xina, Tonn, Torsten, Hugo, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995854/ https://www.ncbi.nlm.nih.gov/pubmed/35434688 http://dx.doi.org/10.1016/j.lanepe.2022.100371 |
Ejemplares similares
-
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
por: Stumpf, Julian, et al.
Publicado: (2021) -
MMF/MPA Is the Main Mediator of a Delayed Humoral Response With Reduced Antibody Decline in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
por: Stumpf, Julian, et al.
Publicado: (2022) -
Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type
por: Stumpf, Julian, et al.
Publicado: (2022) -
10-Year Evaluation of Adherence and Satisfaction with Information about Tolvaptan in ADPKD: A Single-Center Pilot Study
por: Schirutschke, Holger, et al.
Publicado: (2021) -
VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013)